Sign in

    Benjamin Mogil

    Research Analyst at Stifel Nicolaus

    Benjamin Mogil is an analyst at Stifel Nicolaus specializing in the Services sector, where he currently covers specific companies including Madison Square Garden Entertainment and Madison Square Garden Sports. According to TipRanks, Mogil has tracked a success rate of 42.86% across his stock recommendations, with a 1.24-star rating reflecting his historical performance metrics. His career at Stifel Nicolaus has included notable analytical commentary on entertainment-related companies, and previous public records highlight his role in sector research and client advisories. Mogil is FINRA registered and maintains the requisite securities licenses for equity research and analysis in the US financial industry.

    Benjamin Mogil's questions to Regencell Bioscience Holdings (RGC) leadership

    Benjamin Mogil's questions to Regencell Bioscience Holdings (RGC) leadership • Q2 2016

    Question

    Benjamin Mogil from Stifel Nicolaus asked about the industry's screen supply growth, noting that major exhibitors seemed to be growing at a slower pace. He also inquired about the role of developers in financing new theatre construction.

    Answer

    Executive VP, CFO & Treasurer David H. Ownby explained that Regal's capital is prioritized for high-return recliner renovations, which increase market share without adding screens. Chairman & CEO Amy E. Miles added that overall industry growth is within historical norms and noted a positive shift where developers are increasingly interested in funding luxury theatre projects, creating new opportunities for the company.

    Ask Fintool Equity Research AI